-
Product Insights
Sentinel Copper Mine
The Sentinel Copper Mine is a copper mine in Zambia. It is currently in operation. Empower your strategies with our Sentinel Copper Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
CPV Sentinel Energy Project
CPV Sentinel Energy Project is a thermal project located in California, United States. The project is owned by Climate Adaptive Infrastructure LLC; Diamond Generating Corp; Voltage Finance LLC. The project came online in 2013. Empower your strategies with our CPV Sentinel Energy Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Fragile X Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Fragile X Syndrome - Drugs In Development, 2023’, provides an overview of the Fragile X Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fragile X Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Helicobacter Pylori Tests Market Report Overview The Helicobacter Pylori Tests market size was valued at $338.5 million in 2023. The Helicobacter Pylori Tests market will grow at a CAGR of more than 2% from 2023 to 2033. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies such as peptic ulcer disease, gastric MALT lymphoma and gastric cancer as 89%...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SND-002 in Metastatic Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SND-002 in Metastatic Melanoma Drug Details:SND-002 (Sentoclone) is under development for the treatment of malignant melanoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Mantle Cell Lymphoma Drug Details: PEP-07 (CASC-578) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Refractory Acute Myeloid Leukemia Drug Details: PEP-07 (CASC-578)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-07 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-07 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-07 in Relapsed Acute Myeloid Leukemia Drug Details: PEP-07 (CASC-578)...
-
Thematic Analysis
Counter-Drone Technologies – Thematic Intelligence
Explore trends and insights from the following data in our ‘Counter-Drone Technologies’ thematic report: Key challenges that Defence forces and sector suppliers face. Details on investment opportunities for armed forces, suppliers, and institutional investors, across the whole counter-drone value chain. Highlights from different counter-drone technology-related research and development programs that are currently being undertaken by various military organizations and defense companies. Studies of emerging technological trends and their broader impact on the defense market. Analysis of the various C-UAS platforms,...
-
Product Insights
Remote Patient Monitoring Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Remote Patient Monitoring Pipeline Market Report Overview Remote patient monitoring devices are used to retrieve and transmit data through a wireless system to a monitoring station or a physician’s office for further analysis and interpretation. The Remote Patient Monitoring pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...